SAPHETY: Assessing the Safety of Personalized Phage Therapeutic Products KU Leuven
The looming antimicrobial resistance crisis has spurred fresh interest in using naturally occurring bacterial viruses (bacteriophages) to treat bacterial infections, a process termed phage therapy (PT). Although they are generally regarded as safe, phages pose a problem for regulatory bodies in that they don’t fit the classical approval pathway for medicinal products. Since 2018, as the first country in Europe, Belgium has implemented a ...